Recruiting
Coronary artery disease
RecruitingStudy on the Use of SYN2, Adenosine, and Regadenoson for Diagnosing Coronary Artery Disease in Patients with Suspected Heart Conditions
Registered drugNo placebo
Study on the Use of SYN2, Adenosine, and Regadenoson for Diagnosing Coronary Artery Disease in Patients with Suspected Heart Conditions
Registered drugNo placebo
- Disease:Coronary artery disease
- Substances:AdenosineRegadenoson
Countries:
Finland
Finland- Participants:18–64 years · 65+ years
- Substances:Adenosine
- Sponsor:Syn2bio S.A.




